IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

AMRI completes acquisition of API firm Cedarburg

12:20 AM MDT | April 7, 2014 | Deepti Ramesh

Albany Molecular Research Inc. (AMRI; Albany, NY) says that it has completed the previously announced acquisition of Cedarburg Hauser Pharmaceuticals (Grafton, WI). Total consideration that's been paid is $41 million, including assumption of certain liabilities. AMRI financed the transaction with cash on hand. Cedarburg is a contract developer and manufacturer of technically complex active pharmaceutical ingredients (APIs) for both generic and branded customers. Cedarburg's revenue forecast for full-year 2014 is about $19 million, AMRI says. The acquisition is...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa